nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP3A4—Temozolomide—melanoma	0.326	0.385	CbGbCtD
Dihydrocodeine—CYP2D6—Vemurafenib—melanoma	0.281	0.332	CbGbCtD
Dihydrocodeine—CYP3A4—Vemurafenib—melanoma	0.179	0.211	CbGbCtD
Dihydrocodeine—CYP3A4—Docetaxel—melanoma	0.0613	0.0724	CbGbCtD
Dihydrocodeine—Hepatic enzyme increased—Temozolomide—melanoma	0.00335	0.0252	CcSEcCtD
Dihydrocodeine—Angiopathy—Vemurafenib—melanoma	0.00283	0.0212	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Vemurafenib—melanoma	0.00281	0.0211	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00229	0.0172	CcSEcCtD
Dihydrocodeine—Affect lability—Temozolomide—melanoma	0.00227	0.017	CcSEcCtD
Dihydrocodeine—Mood swings—Temozolomide—melanoma	0.00218	0.0164	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Vemurafenib—melanoma	0.00217	0.0163	CcSEcCtD
Dihydrocodeine—Skin disorder—Vemurafenib—melanoma	0.00215	0.0161	CcSEcCtD
Dihydrocodeine—Hypotension—Vemurafenib—melanoma	0.00207	0.0155	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00191	0.0143	CcSEcCtD
Dihydrocodeine—Constipation—Vemurafenib—melanoma	0.00189	0.0142	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Temozolomide—melanoma	0.00168	0.0126	CcSEcCtD
Dihydrocodeine—Hallucination—Carmustine—melanoma	0.00164	0.0123	CcSEcCtD
Dihydrocodeine—Hallucination—Temozolomide—melanoma	0.00159	0.0119	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Temozolomide—melanoma	0.00157	0.0118	CcSEcCtD
Dihydrocodeine—Pruritus—Vemurafenib—melanoma	0.00157	0.0118	CcSEcCtD
Dihydrocodeine—Urethral disorder—Temozolomide—melanoma	0.00156	0.0117	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vemurafenib—melanoma	0.00152	0.0114	CcSEcCtD
Dihydrocodeine—Dizziness—Vemurafenib—melanoma	0.00146	0.011	CcSEcCtD
Dihydrocodeine—Angiopathy—Temozolomide—melanoma	0.00145	0.0108	CcSEcCtD
Dihydrocodeine—Mental disorder—Carmustine—melanoma	0.00144	0.0108	CcSEcCtD
Dihydrocodeine—Immune system disorder—Temozolomide—melanoma	0.00144	0.0108	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Temozolomide—melanoma	0.00144	0.0108	CcSEcCtD
Dihydrocodeine—Vomiting—Vemurafenib—melanoma	0.00141	0.0106	CcSEcCtD
Dihydrocodeine—Rash—Vemurafenib—melanoma	0.0014	0.0105	CcSEcCtD
Dihydrocodeine—Mental disorder—Temozolomide—melanoma	0.0014	0.0105	CcSEcCtD
Dihydrocodeine—Dermatitis—Vemurafenib—melanoma	0.0014	0.0105	CcSEcCtD
Dihydrocodeine—Headache—Vemurafenib—melanoma	0.00139	0.0104	CcSEcCtD
Dihydrocodeine—Confusional state—Bleomycin—melanoma	0.00135	0.0101	CcSEcCtD
Dihydrocodeine—Nausea—Vemurafenib—melanoma	0.00132	0.00987	CcSEcCtD
Dihydrocodeine—Angioedema—Temozolomide—melanoma	0.00127	0.00951	CcSEcCtD
Dihydrocodeine—Hypotension—Bleomycin—melanoma	0.00125	0.00941	CcSEcCtD
Dihydrocodeine—Vertigo—Temozolomide—melanoma	0.00125	0.00935	CcSEcCtD
Dihydrocodeine—Convulsion—Carmustine—melanoma	0.00124	0.00933	CcSEcCtD
Dihydrocodeine—Paraesthesia—Bleomycin—melanoma	0.0012	0.00904	CcSEcCtD
Dihydrocodeine—Convulsion—Temozolomide—melanoma	0.0012	0.00901	CcSEcCtD
Dihydrocodeine—Dyspnoea—Bleomycin—melanoma	0.0012	0.00897	CcSEcCtD
Dihydrocodeine—Confusional state—Carmustine—melanoma	0.00118	0.00886	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00117	0.0088	CcSEcCtD
Dihydrocodeine—Dry mouth—Temozolomide—melanoma	0.00115	0.00866	CcSEcCtD
Dihydrocodeine—Confusional state—Temozolomide—melanoma	0.00114	0.00856	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Docetaxel—melanoma	0.00112	0.00837	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Temozolomide—melanoma	0.00111	0.00833	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Bleomycin—melanoma	0.00111	0.0083	CcSEcCtD
Dihydrocodeine—Skin disorder—Temozolomide—melanoma	0.0011	0.00825	CcSEcCtD
Dihydrocodeine—Hypotension—Carmustine—melanoma	0.00109	0.00821	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Temozolomide—melanoma	0.00109	0.00821	CcSEcCtD
Dihydrocodeine—Urticaria—Bleomycin—melanoma	0.00107	0.008	CcSEcCtD
Dihydrocodeine—Paraesthesia—Carmustine—melanoma	0.00105	0.00789	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Docetaxel—melanoma	0.00105	0.00785	CcSEcCtD
Dihydrocodeine—Dyspnoea—Carmustine—melanoma	0.00104	0.00783	CcSEcCtD
Dihydrocodeine—Somnolence—Carmustine—melanoma	0.00104	0.00781	CcSEcCtD
Dihydrocodeine—Urethral disorder—Docetaxel—melanoma	0.00104	0.00779	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Dactinomycin—melanoma	0.00103	0.00774	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Dactinomycin—melanoma	0.00102	0.00768	CcSEcCtD
Dihydrocodeine—Paraesthesia—Temozolomide—melanoma	0.00102	0.00762	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Carmustine—melanoma	0.00101	0.00759	CcSEcCtD
Dihydrocodeine—Dyspnoea—Temozolomide—melanoma	0.00101	0.00757	CcSEcCtD
Dihydrocodeine—Somnolence—Temozolomide—melanoma	0.00101	0.00755	CcSEcCtD
Dihydrocodeine—Constipation—Carmustine—melanoma	0.001	0.00751	CcSEcCtD
Dihydrocodeine—Abdominal pain—Dactinomycin—melanoma	0.000989	0.00742	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Temozolomide—melanoma	0.000977	0.00733	CcSEcCtD
Dihydrocodeine—Constipation—Temozolomide—melanoma	0.000968	0.00726	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Carmustine—melanoma	0.000965	0.00724	CcSEcCtD
Dihydrocodeine—Angiopathy—Docetaxel—melanoma	0.000961	0.00721	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Carmustine—melanoma	0.000958	0.00719	CcSEcCtD
Dihydrocodeine—Immune system disorder—Docetaxel—melanoma	0.000957	0.00718	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Docetaxel—melanoma	0.000955	0.00716	CcSEcCtD
Dihydrocodeine—Pruritus—Bleomycin—melanoma	0.000949	0.00712	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Temozolomide—melanoma	0.000933	0.007	CcSEcCtD
Dihydrocodeine—Mental disorder—Docetaxel—melanoma	0.000928	0.00696	CcSEcCtD
Dihydrocodeine—Abdominal pain—Carmustine—melanoma	0.000926	0.00695	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Temozolomide—melanoma	0.000925	0.00694	CcSEcCtD
Dihydrocodeine—Urticaria—Temozolomide—melanoma	0.000899	0.00675	CcSEcCtD
Dihydrocodeine—Abdominal pain—Temozolomide—melanoma	0.000895	0.00671	CcSEcCtD
Dihydrocodeine—Diarrhoea—Dactinomycin—melanoma	0.000856	0.00642	CcSEcCtD
Dihydrocodeine—Vomiting—Bleomycin—melanoma	0.000853	0.0064	CcSEcCtD
Dihydrocodeine—Rash—Bleomycin—melanoma	0.000846	0.00635	CcSEcCtD
Dihydrocodeine—Dermatitis—Bleomycin—melanoma	0.000845	0.00634	CcSEcCtD
Dihydrocodeine—Diarrhoea—Carmustine—melanoma	0.000801	0.00601	CcSEcCtD
Dihydrocodeine—Pruritus—Temozolomide—melanoma	0.000801	0.00601	CcSEcCtD
Dihydrocodeine—Convulsion—Docetaxel—melanoma	0.000799	0.00599	CcSEcCtD
Dihydrocodeine—Nausea—Bleomycin—melanoma	0.000797	0.00598	CcSEcCtD
Dihydrocodeine—Vomiting—Dactinomycin—melanoma	0.000796	0.00597	CcSEcCtD
Dihydrocodeine—Rash—Dactinomycin—melanoma	0.000789	0.00592	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00078	0.00585	CcSEcCtD
Dihydrocodeine—Dizziness—Carmustine—melanoma	0.000774	0.00581	CcSEcCtD
Dihydrocodeine—Diarrhoea—Temozolomide—melanoma	0.000774	0.00581	CcSEcCtD
Dihydrocodeine—Dry mouth—Docetaxel—melanoma	0.000768	0.00576	CcSEcCtD
Dihydrocodeine—Confusional state—Docetaxel—melanoma	0.000759	0.00569	CcSEcCtD
Dihydrocodeine—Dizziness—Temozolomide—melanoma	0.000748	0.00562	CcSEcCtD
Dihydrocodeine—Vomiting—Carmustine—melanoma	0.000745	0.00559	CcSEcCtD
Dihydrocodeine—Nausea—Dactinomycin—melanoma	0.000743	0.00558	CcSEcCtD
Dihydrocodeine—Rash—Carmustine—melanoma	0.000738	0.00554	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Docetaxel—melanoma	0.000738	0.00554	CcSEcCtD
Dihydrocodeine—Dermatitis—Carmustine—melanoma	0.000738	0.00554	CcSEcCtD
Dihydrocodeine—Headache—Carmustine—melanoma	0.000734	0.0055	CcSEcCtD
Dihydrocodeine—Skin disorder—Docetaxel—melanoma	0.000731	0.00548	CcSEcCtD
Dihydrocodeine—Vomiting—Temozolomide—melanoma	0.00072	0.0054	CcSEcCtD
Dihydrocodeine—Rash—Temozolomide—melanoma	0.000714	0.00535	CcSEcCtD
Dihydrocodeine—Dermatitis—Temozolomide—melanoma	0.000713	0.00535	CcSEcCtD
Dihydrocodeine—Headache—Temozolomide—melanoma	0.000709	0.00532	CcSEcCtD
Dihydrocodeine—Hypotension—Docetaxel—melanoma	0.000703	0.00528	CcSEcCtD
Dihydrocodeine—Nausea—Carmustine—melanoma	0.000696	0.00522	CcSEcCtD
Dihydrocodeine—Paraesthesia—Docetaxel—melanoma	0.000676	0.00507	CcSEcCtD
Dihydrocodeine—Nausea—Temozolomide—melanoma	0.000672	0.00504	CcSEcCtD
Dihydrocodeine—Dyspnoea—Docetaxel—melanoma	0.000671	0.00503	CcSEcCtD
Dihydrocodeine—Somnolence—Docetaxel—melanoma	0.000669	0.00502	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Docetaxel—melanoma	0.00065	0.00488	CcSEcCtD
Dihydrocodeine—Constipation—Docetaxel—melanoma	0.000644	0.00483	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Docetaxel—melanoma	0.00062	0.00465	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Docetaxel—melanoma	0.000615	0.00462	CcSEcCtD
Dihydrocodeine—Abdominal pain—Docetaxel—melanoma	0.000595	0.00446	CcSEcCtD
Dihydrocodeine—Pruritus—Docetaxel—melanoma	0.000533	0.004	CcSEcCtD
Dihydrocodeine—Diarrhoea—Docetaxel—melanoma	0.000515	0.00386	CcSEcCtD
Dihydrocodeine—Dizziness—Docetaxel—melanoma	0.000498	0.00373	CcSEcCtD
Dihydrocodeine—Vomiting—Docetaxel—melanoma	0.000479	0.00359	CcSEcCtD
Dihydrocodeine—Rash—Docetaxel—melanoma	0.000475	0.00356	CcSEcCtD
Dihydrocodeine—Dermatitis—Docetaxel—melanoma	0.000474	0.00356	CcSEcCtD
Dihydrocodeine—Headache—Docetaxel—melanoma	0.000472	0.00354	CcSEcCtD
Dihydrocodeine—Nausea—Docetaxel—melanoma	0.000447	0.00335	CcSEcCtD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—MAPK1—melanoma	5.28e-05	0.00261	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GRM3—melanoma	5.27e-05	0.00261	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—CYP17A1—melanoma	5.17e-05	0.00256	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	5.1e-05	0.00252	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—F2RL1—melanoma	5.09e-05	0.00252	CbGpPWpGaD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—AKT1—melanoma	5.05e-05	0.0025	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—KISS1—melanoma	5e-05	0.00247	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	4.93e-05	0.00244	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CXCR4—melanoma	4.9e-05	0.00243	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCR1—melanoma	4.84e-05	0.0024	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GRM3—melanoma	4.79e-05	0.00237	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—MC1R—melanoma	4.77e-05	0.00236	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TAS2R60—melanoma	4.67e-05	0.00231	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GRM1—melanoma	4.57e-05	0.00226	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CCR7—melanoma	4.57e-05	0.00226	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—KISS1—melanoma	4.54e-05	0.00225	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCR1—melanoma	4.39e-05	0.00218	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—CYP1B1—melanoma	4.35e-05	0.00215	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MC1R—melanoma	4.33e-05	0.00214	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	4.29e-05	0.00212	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—HRAS—melanoma	4.24e-05	0.0021	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—RHOB—melanoma	4.16e-05	0.00206	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GRM1—melanoma	4.15e-05	0.00205	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCR7—melanoma	4.15e-05	0.00205	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL6—melanoma	4.06e-05	0.00201	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—CXCL8—melanoma	3.98e-05	0.00197	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	3.82e-05	0.00189	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCR2—melanoma	3.79e-05	0.00187	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—RHOB—melanoma	3.78e-05	0.00187	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—EDN1—melanoma	3.76e-05	0.00186	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—AKT1—melanoma	3.75e-05	0.00185	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—RAC2—melanoma	3.73e-05	0.00184	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL1—melanoma	3.54e-05	0.00175	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PLCB4—melanoma	3.54e-05	0.00175	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCR2—melanoma	3.44e-05	0.0017	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—RAC2—melanoma	3.38e-05	0.00167	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.38e-05	0.00167	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—CXCL8—melanoma	3.35e-05	0.00166	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.34e-05	0.00165	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—WNT5A—melanoma	3.33e-05	0.00165	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CUL3—melanoma	3.33e-05	0.00165	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TRRAP—melanoma	3.33e-05	0.00165	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKR1B10—melanoma	3.24e-05	0.0016	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—F2R—melanoma	3.22e-05	0.00159	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—EDNRB—melanoma	3.12e-05	0.00154	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—F2RL1—melanoma	3.01e-05	0.00149	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GAB2—melanoma	2.95e-05	0.00146	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GNA11—melanoma	2.95e-05	0.00146	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—F2R—melanoma	2.92e-05	0.00145	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ACER3—melanoma	2.9e-05	0.00144	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.85e-05	0.00141	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EDNRB—melanoma	2.83e-05	0.0014	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GRM3—melanoma	2.83e-05	0.0014	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.81e-05	0.00139	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCR4—melanoma	2.77e-05	0.00137	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GNAQ—melanoma	2.74e-05	0.00136	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KISS1—melanoma	2.68e-05	0.00133	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GNA11—melanoma	2.67e-05	0.00132	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GAB2—melanoma	2.67e-05	0.00132	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	2.67e-05	0.00132	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—UGT2B10—melanoma	2.65e-05	0.00131	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCR1—melanoma	2.6e-05	0.00128	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SKI—melanoma	2.6e-05	0.00128	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MC1R—melanoma	2.56e-05	0.00127	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT3—melanoma	2.53e-05	0.00125	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCR4—melanoma	2.51e-05	0.00124	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GNAQ—melanoma	2.49e-05	0.00123	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HS3ST5—melanoma	2.47e-05	0.00122	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GRM1—melanoma	2.45e-05	0.00121	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCR7—melanoma	2.45e-05	0.00121	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SUFU—melanoma	2.39e-05	0.00118	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT3—melanoma	2.29e-05	0.00114	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RHOB—melanoma	2.23e-05	0.0011	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—BCL2L11—melanoma	2.23e-05	0.0011	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HDAC6—melanoma	2.14e-05	0.00106	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—EDN1—melanoma	2.12e-05	0.00105	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CSF2—melanoma	2.08e-05	0.00103	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCR2—melanoma	2.03e-05	0.00101	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CXCL8—melanoma	2.03e-05	0.001	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RAC2—melanoma	2e-05	0.000989	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PRKCA—melanoma	1.99e-05	0.000985	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—WNT5A—melanoma	1.97e-05	0.000974	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFC—melanoma	1.97e-05	0.000974	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EDN1—melanoma	1.93e-05	0.000954	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ACER3—melanoma	1.9e-05	0.000939	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CSF2—melanoma	1.88e-05	0.000933	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLCB4—melanoma	1.87e-05	0.000926	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—RAC1—melanoma	1.84e-05	0.000913	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PRKCA—melanoma	1.81e-05	0.000894	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAP2K2—melanoma	1.77e-05	0.000874	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC6A11—melanoma	1.76e-05	0.00087	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIP4K2A—melanoma	1.76e-05	0.00087	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UGT2B10—melanoma	1.74e-05	0.000859	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—F2R—melanoma	1.73e-05	0.000855	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTAP—melanoma	1.71e-05	0.000846	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—RAC1—melanoma	1.67e-05	0.000829	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDNRB—melanoma	1.67e-05	0.000828	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTK2B—melanoma	1.62e-05	0.000804	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HS3ST5—melanoma	1.61e-05	0.000798	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GAB2—melanoma	1.58e-05	0.000782	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GNA11—melanoma	1.58e-05	0.000782	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FLT1—melanoma	1.57e-05	0.000778	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CG—melanoma	1.56e-05	0.000771	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PHGDH—melanoma	1.52e-05	0.000754	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LUM—melanoma	1.52e-05	0.000754	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HPSE—melanoma	1.5e-05	0.00074	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCR4—melanoma	1.49e-05	0.000735	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HDAC2—melanoma	1.49e-05	0.000735	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FOXO4—melanoma	1.49e-05	0.000735	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GNAQ—melanoma	1.47e-05	0.000727	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CUBN—melanoma	1.47e-05	0.000726	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—BSG—melanoma	1.42e-05	0.000701	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SDHD—melanoma	1.42e-05	0.000701	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CSPG4—melanoma	1.42e-05	0.000701	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CG—melanoma	1.42e-05	0.0007	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SYK—melanoma	1.38e-05	0.000683	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GPAM—melanoma	1.37e-05	0.000679	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CD—melanoma	1.37e-05	0.000678	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT3—melanoma	1.36e-05	0.000671	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ITGAV—melanoma	1.36e-05	0.000671	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NGFR—melanoma	1.36e-05	0.000671	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SOCS1—melanoma	1.26e-05	0.000621	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAP2K1—melanoma	1.25e-05	0.00062	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—S100B—melanoma	1.25e-05	0.00062	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CD—melanoma	1.24e-05	0.000616	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLCB4—melanoma	1.22e-05	0.000605	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB4—melanoma	1.2e-05	0.000593	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	1.19e-05	0.000591	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN2B—melanoma	1.19e-05	0.000587	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLA2G6—melanoma	1.17e-05	0.000578	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.15e-05	0.000569	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC6A11—melanoma	1.15e-05	0.000569	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CD86—melanoma	1.15e-05	0.000568	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCL8—melanoma	1.15e-05	0.000568	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDN1—melanoma	1.14e-05	0.000564	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTAP—melanoma	1.12e-05	0.000553	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CSF2—melanoma	1.11e-05	0.000551	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF1—melanoma	1.11e-05	0.000551	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—IL2—melanoma	1.1e-05	0.000543	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—E2F1—melanoma	1.09e-05	0.000539	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CB—melanoma	1.08e-05	0.000537	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDGFRA—melanoma	1.08e-05	0.000534	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ITGB3—melanoma	1.07e-05	0.000528	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKCA—melanoma	1.07e-05	0.000528	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—VCAN—melanoma	1.05e-05	0.000519	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SPP1—melanoma	1.05e-05	0.000518	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAP2K2—melanoma	1.04e-05	0.000516	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCL8—melanoma	1.04e-05	0.000516	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PHGDH—melanoma	9.97e-06	0.000493	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LUM—melanoma	9.97e-06	0.000493	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL2—melanoma	9.96e-06	0.000493	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TERT—melanoma	9.92e-06	0.000491	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RAC1—melanoma	9.89e-06	0.00049	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HPSE—melanoma	9.77e-06	0.000484	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CUBN—melanoma	9.59e-06	0.000475	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HIF1A—melanoma	9.49e-06	0.00047	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SDHD—melanoma	9.27e-06	0.000459	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CSPG4—melanoma	9.27e-06	0.000459	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—BSG—melanoma	9.27e-06	0.000459	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KDR—melanoma	9.07e-06	0.000449	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPAM—melanoma	8.97e-06	0.000444	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP17A1—melanoma	8.85e-06	0.000438	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FN1—melanoma	8.73e-06	0.000432	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOTCH1—melanoma	8.55e-06	0.000423	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CD80—melanoma	8.37e-06	0.000414	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APC—melanoma	8.36e-06	0.000414	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KIT—melanoma	8.36e-06	0.000414	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CG—melanoma	8.36e-06	0.000414	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—NRAS—melanoma	8.36e-06	0.000414	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GNA11—melanoma	8.35e-06	0.000413	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGF—melanoma	8.26e-06	0.000409	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—FASN—melanoma	8.17e-06	0.000405	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC5A5—melanoma	8.04e-06	0.000398	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAPK3—melanoma	8.01e-06	0.000396	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—BRAF—melanoma	7.86e-06	0.000389	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GNAQ—melanoma	7.77e-06	0.000384	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CD44—melanoma	7.77e-06	0.000384	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1—melanoma	7.65e-06	0.000379	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLA2G6—melanoma	7.63e-06	0.000378	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAPK1—melanoma	7.62e-06	0.000377	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EGFR—melanoma	7.62e-06	0.000377	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1B1—melanoma	7.45e-06	0.000368	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAP2K1—melanoma	7.4e-06	0.000366	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CD—melanoma	7.35e-06	0.000364	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	7.28e-06	0.00036	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—KRAS—melanoma	7.19e-06	0.000356	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF2—melanoma	7.04e-06	0.000348	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—VCAN—melanoma	6.85e-06	0.000339	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CA—melanoma	6.61e-06	0.000327	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MDM2—melanoma	6.58e-06	0.000326	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB2—melanoma	6.49e-06	0.000321	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CB—melanoma	6.41e-06	0.000317	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL8—melanoma	6.16e-06	0.000305	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCB1—melanoma	6.13e-06	0.000303	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HRAS—melanoma	6.12e-06	0.000303	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1B—melanoma	6.01e-06	0.000297	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT1—melanoma	5.95e-06	0.000294	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP3—melanoma	5.89e-06	0.000292	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL2—melanoma	5.88e-06	0.000291	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—melanoma	5.85e-06	0.00029	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP17A1—melanoma	5.78e-06	0.000286	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCND1—melanoma	5.73e-06	0.000284	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CTNNB1—melanoma	5.68e-06	0.000281	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PRKCA—melanoma	5.64e-06	0.000279	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ERCC2—melanoma	5.6e-06	0.000277	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP9—melanoma	5.57e-06	0.000276	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1A—melanoma	5.55e-06	0.000275	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTEN—melanoma	5.53e-06	0.000274	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NFKB1—melanoma	5.51e-06	0.000273	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GNA11—melanoma	5.46e-06	0.00027	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT1—melanoma	5.4e-06	0.000267	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—FASN—melanoma	5.34e-06	0.000264	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC5A5—melanoma	5.26e-06	0.00026	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CD44—melanoma	5.08e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GNAQ—melanoma	5.08e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—melanoma	5e-06	0.000247	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT3—melanoma	4.95e-06	0.000245	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NRAS—melanoma	4.94e-06	0.000244	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1B1—melanoma	4.87e-06	0.000241	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK3—melanoma	4.73e-06	0.000234	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MYC—melanoma	4.6e-06	0.000228	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK1—melanoma	4.5e-06	0.000223	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGFR—melanoma	4.5e-06	0.000223	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CG—melanoma	4.42e-06	0.000219	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARG—melanoma	4.27e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KRAS—melanoma	4.25e-06	0.00021	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCB1—melanoma	4.01e-06	0.000198	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CA—melanoma	3.9e-06	0.000193	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CD—melanoma	3.89e-06	0.000192	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALB—melanoma	3.84e-06	0.00019	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TP53—melanoma	3.78e-06	0.000187	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PRKCA—melanoma	3.69e-06	0.000183	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ERCC2—melanoma	3.66e-06	0.000181	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HRAS—melanoma	3.61e-06	0.000179	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—melanoma	3.46e-06	0.000171	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CB—melanoma	3.39e-06	0.000168	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTGS2—melanoma	3.36e-06	0.000166	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT1—melanoma	3.19e-06	0.000158	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTEN—melanoma	2.93e-06	0.000145	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CG—melanoma	2.89e-06	0.000143	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARG—melanoma	2.79e-06	0.000138	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CD—melanoma	2.54e-06	0.000126	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALB—melanoma	2.51e-06	0.000124	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CB—melanoma	2.21e-06	0.00011	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTGS2—melanoma	2.19e-06	0.000109	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CA—melanoma	2.06e-06	0.000102	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTEN—melanoma	1.91e-06	9.47e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKT1—melanoma	1.69e-06	8.35e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CA—melanoma	1.35e-06	6.68e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKT1—melanoma	1.1e-06	5.46e-05	CbGpPWpGaD
